In both highly angiogenic ovarian and renal cancer models, we show that miR-192 significantly disrupts the crosstalk between tumour and endothelial cells by targeting two key transcription factors, EGR1 and HOXB9. This led to global downregulation of pro-angiogenic factors. The gene discussed is EGR1; the disease is neoplasm.